GlassScriptPhysician profile
Rosanne R Dalton
NPI 1235133133
$1,517.51
in general payments reported to CMS, 2019-2025
23 companies · $226 in 2025
The $226 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $150 · 2021: $291 · 2022: $266 · 2023: $165 · 2024: $185 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $235.11 | 2021-2022 | |
| Glaxosmithkline, LLC. | $196.57 | 2019-2025 | Bexsero, Shingrix |
| Tris Pharma INC | $163.40 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $140.39 | 2023-2025 | Azstarys, Azstarys |
| Neos Therapeutics, LP | $116.23 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.22 | 2019-2025 | Elaprase |
| Merck Sharp & Dohme LLC | $53.00 | 2021-2024 | Vaxelis, Gardasil 9, M-M-R II |
| Novo Nordisk INC | $49.10 | 2024 | |
| Novartis Pharmaceuticals Corporation | $45.95 | 2019 | |
| Pfizer INC. | $45.85 | 2019-2023 | |
| Sobi, INC | $45.58 | 2019-2022 | |
| Kaleo, INC. | $44.29 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $42.58 | 2025 | |
| Abbvie INC. | $41.60 | 2020-2021 | |
| Genentech USA, INC. | $38.35 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $36.28 | 2023-2024 | Immunocap |
| Collegium Pharmaceutical, INC. | $35.07 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $29.40 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $26.32 | 2021 | |
| Seqirus USA INC | $25.18 | 2023 | Flucelvax Quadrivalent |
| Sun Pharmaceutical Industries INC. | $18.44 | 2020 | |
| Allergan, INC. | $17.23 | 2020 | |
| Cranial Technologies, INC | $13.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosanne Dalton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.